Inteliquet, an IQVIA business, leverages advanced technologies to enhance clinical trial efficiency and patient engagement. Their platform utilizes real-time data analytics and artificial intelligence to optimize trial design and patient recruitment, ensuring that studies are more targeted and effective. By integrating diverse data sources, Inteliquet provides insights that help researchers identify suitable candidates for clinical trials, thereby accelerating the drug development process.

Additionally, Inteliquet emphasizes the importance of patient-centric approaches in clinical research. Their technology facilitates better communication between patients and trial sponsors, allowing for a more streamlined experience. By employing tools that enhance patient engagement and retention, Inteliquet aims to improve overall trial outcomes and ensure that the right therapies reach the right patients in a timely manner.

United States

Inteliquet, an IQVIA business, Inteliquet is a leading provider of innovative technology and comprehensive support services for cancer clinical researchers. We bridge sponsors, patients and cancer centers nationwide for the ultimate purpose of increasing patient access to cancer trial treatment options. From trial selection to patient matching, Inteliquet enables a streamlined and more accurate journey to patient enrollment.

To learn more about Inteliquet, visit https://inteliquet.com/

Inteliquet, an IQVIA business

Company Details